We identified a collection of novel candidate EC-implicated lncRNAs that are relevant to diverse biologic processes, and identified a novel tumor-suppressive lncRNA, SOCS2-AS1, with crucial biologic and clinical impact on EC. This evidence concerns the gene SOCS2 and neoplasm.